The Rutgers Cancer Institute of New Jersey is a cancer treatment and research institution that is a part of Rutgers University and located in New Brunswick, New Jersey.

During the past decade, Rutgers Cancer Institute of New Jersey conducted 370 clinical trials. In the 10-year time frame, 370 clinical trials started and 221 clinical trials were completed, i.e. on average, 59.7% percent of trials that started reached the finish line to date. In the past 5 years, 161 clinical trials started and 108 clinical trials were completed. i.e. 67.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rutgers Cancer Institute of New Jersey" #1 sponsor was "National Cancer Institute (NCI)" with 158 trials, followed by "Rutgers, The State University of New Jersey" with 113 trials sponsored, "Children's Oncology Group" with 48 trials sponsored, "Radiation Therapy Oncology Group" with 38 trials sponsored and "Eastern Cooperative Oncology Group" with 38 trials sponsored. Other sponsors include 420 different institutions and companies that sponsored additional 178 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Cancer Institute of New Jersey" #1 collaborator was "National Cancer Institute (NCI)" with 351 trials as a collaborator, "Rutgers Cancer Institute of New Jersey" with 55 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Merck Sharp & Dohme LLC" with 15 trials as a collaborator and "SWOG Cancer Research Network" with 15 trials as a collaborator. Other collaborators include 326 different institutions and companies that were collaborators in the rest 178 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers Cancer Institute of New Jersey" are "Breast Cancer" (57 trials), "Prostate Cancer" (51 trials), "Leukemia" (36 trials), "Lymphoma" (34 trials) and "Lung Cancer" (24 trials). Many other conditions were trialed in "Rutgers Cancer Institute of New Jersey" in a lesser frequency.

Most popular intervention types in "Rutgers Cancer Institute of New Jersey" are "Drug" (638 trials), "Other" (211 trials), "Biological" (199 trials), "Radiation" (140 trials) and "Procedure" (138 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (58 trials), "radiation therapy" (50 trials), "Paclitaxel" (48 trials) and "Questionnaire Administration" (46 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers Cancer Institute of New Jersey" are 629 trials for "All" genders, 111 trials for "Female" genders and 79 trials for "Male" genders.

Currently, there are NaN active trials in "Rutgers Cancer Institute of New Jersey". 2 are not yet recruiting, 141 are recruiting, 171 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 354 completed trials in Rutgers Cancer Institute of New Jersey, 8 suspended trials, and 103 terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers Cancer Institute of New Jersey, 175 "Phase 1" clinical trials were conducted, 397 "Phase 2" clinical trials and 231 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 59 trials that are defined as “Not Applicable".

Rutgers Cancer Institute of New Jersey has several departments that took part in Clinical trials: "Rutgers Cancer Institute of New Jersey,100 State Route 36" - 4 trials, "Rutgers Cancer Institute of New Jersey,150 Bergen St." - 2 trials, "University Hospital/New Jersey Cancer Center" - 2 trials